Wu, Chan-yuan
Wang, Qian
Shi, Jian
Zhang, Xiu-ying
Du, Rong
Gu, Jie-ruo
Liu, Qi-huan
Yu, Jiao
Xu, Jia-wei
Zhang, Yan-jie
Zhu, Hao
Li, Meng-tao
Zeng, Xiao-feng http://orcid.org/0000-0002-3883-2318
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 28 June 2023
Accepted: 29 August 2023
First Online: 28 September 2023
Declarations
:
: Yu Jiao, Xu Jia-wei, Zhang Yan-jie, and Zhu Hao are employees of Eli Lilly and Company, Suzhou, China. Wu Chan-yuan, Wang Qian, Shi Jian, Zhang Xiu-ying, Du Rong, Gu Jie-ruo, Liu Qi-huan, Li Meng-tao and Zeng Xiao-feng have no conflicts of interest to declare.
: The PMSS was conducted in compliance with applicable laws in China and in accordance with the Chinese Guidelines for Good Clinical Practice and the principles outlined in the Declaration of Helsinki. The study received IRB and ethics approval at each site (Supplementary Material); the central ethics board was the Peking Union Medical College Hospital Ethics Committee (approval number HS-2327). All participants provided written, informed consent prior to participation.